{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:22:32Z","timestamp":1791501752756,"version":"4.3.4"},"reference-count":182,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>T cells are main actors of the immune system with an essential role in protection against pathogens and cancer. The molecular key event involved in this absolutely central task is the interaction of membrane-bound specific T cell receptors with peptide-MHC complexes which initiates T cell priming, activation and recall, and thus controls a range of downstream functions. While textbooks teach us that the repertoire of mature T cells is highly diverse, it is clear that this diversity cannot possibly cover all potential foreign peptides that might be encountered during life. TCR cross-reactivity, i.e. the ability of a single TCR to recognise different peptides, offers the best solution to this biological challenge. Reports have shown that indeed, TCR cross-reactivity is surprisingly high. Hence, the T cell dilemma is the following: be as specific as possible to target foreign danger and spare self, while being able to react to a large spectrum of body-threatening situations. This has major consequences for both autoimmune diseases and cancer, and significant implications for the development of T cell-based therapies. In this review, we will present essential experimental evidence of T cell cross-reactivity, implications for two opposite immune conditions, i.e. autoimmunity vs cancer, and how this can be differently exploited for immunotherapy approaches. Finally, we will discuss the tools available for predicting cross-reactivity and how improvements in this field might boost translational approaches.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1212546","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T05:53:47Z","timestamp":1687154027000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer"],"prefix":"10.3389","volume":"14","author":[{"given":"C\u00e9cile","family":"Gouttefangeas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhild","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80490-2","article-title":"Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity","volume":"5","author":"Schodin","year":"1996","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s1074-7613(01)00170-4","article-title":"How much TCR does a T cell need","volume":"15","author":"Labrecque","year":"2001","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.12.002","article-title":"The multiple mechanisms of T cell receptor cross-reactivity","volume":"31","author":"Yin","year":"2009","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/351290a0","article-title":"Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules","volume":"351","author":"Falk","year":"1991","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5441.958","article-title":"A direct estimate of the human alphabeta T cell receptor diversity","volume":"286","author":"Arstila","year":"1999","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nri1292","article-title":"The many important facets of T-cell repertoire diversity","volume":"4","author":"Nikolich-Zugich","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00485","article-title":"Estimating the diversity, completeness, and cross-reactivity of the T cell repertoire","volume":"4","author":"Zarnitsyna","year":"2013","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.05.006","article-title":"Identification of cross-reactive CD8(+) T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants","volume":"9","author":"Hu","year":"2022","journal-title":"Genes Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.41.11.849","article-title":"The natural-selection theory of antibody formation","volume":"41","author":"Jerne","year":"1955","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3279","article-title":"Why must T cells be cross-reactive","volume":"12","author":"Sewell","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.immuni.2021.04.006","article-title":"CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses","volume":"54","author":"Lineburg","year":"2021","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00330-07","article-title":"Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes","volume":"81","author":"Imrie","year":"2007","journal-title":"J Virol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/imr.12095","article-title":"Antiviral memory phenotype T cells in unexposed adults","volume":"255","author":"Su","year":"2013","journal-title":"Immunol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature08997","article-title":"Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection","volume":"465","author":"Kosmrlj","year":"2010","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2010.00897.x","article-title":"Heterologous immunity between viruses","volume":"235","author":"Welsh","year":"2010","journal-title":"Immunol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.003","article-title":"T Cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility","volume":"31","author":"Borbulevych","year":"2009","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.4.1259","article-title":"Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands","volume":"184","author":"Kersh","year":"1996","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.8.3631","article-title":"Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology","volume":"160","author":"Hemmer","year":"1998","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/12.3.375","article-title":"Minimal peptide length requirements for CD4(+) T cell clones\u2013implications for molecular mimicry and T cell survival","volume":"12","author":"Hemmer","year":"2000","journal-title":"Int Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.047","article-title":"Deconstructing the peptide-MHC specificity of T cell recognition","volume":"157","author":"Birnbaum","year":"2014","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1682381","article-title":"Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy","volume":"9","author":"Sanderson","year":"2020","journal-title":"Oncoimmunology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.immuni.2009.09.025","article-title":"T Cell allorecognition via molecular mimicry","volume":"31","author":"Macdonald","year":"2009","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.7.3527","article-title":"Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR","volume":"161","author":"Doherty","year":"1998","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.01.008","article-title":"Crossreactive T cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules","volume":"28","author":"Dai","year":"2008","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12622","article-title":"The T cell antigen receptor: the Swiss army knife of the immune system","volume":"181","author":"Attaf","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.10.021","article-title":"Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults","volume":"38","author":"Su","year":"2013","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130555","article-title":"Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors","volume":"211","author":"Campion","year":"2014","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s0167-5699(98)01299-7","article-title":"A very high level of crossreactivity is an essential feature of the T-cell receptor","volume":"19","author":"Mason","year":"1998","journal-title":"Immunol Today"},{"key":"B30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.immuni.2004.11.015","article-title":"Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity","volume":"22","author":"Maynard","year":"2005","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.289488","article-title":"A single autoimmune T cell receptor recognizes more than a million different peptides","volume":"287","author":"Wooldridge","year":"2012","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2385::AID-IMMU2385>3.0.CO;2-B","article-title":"Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases","volume":"29","author":"Hiemstra","year":"1999","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901607","article-title":"Quantitating T cell cross-reactivity for unrelated peptide antigens","volume":"183","author":"Ishizuka","year":"2009","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.7.3236","article-title":"CD8+ memory T cells (CD44high, ly-6C+) are more sensitive than naive cells to (CD44low, ly-6C-) to TCR\/CD8 signaling in response to antigen","volume":"160","author":"Curtsinger","year":"1998","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/76907","article-title":"Response of naive and memory CD8+ T cells to antigen stimulation","volume":"1","author":"Veiga-Fernandes","year":"2000","journal-title":"in vivo. Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI12673","article-title":"Infection, mimics, and autoimmune disease","volume":"107","author":"Rose","year":"2001","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI15198","article-title":"Degeneracy, as opposed to specificity, in immunotherapy","volume":"109","author":"Hafler","year":"2002","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2020.101395","article-title":"Peptide mimotopes alter T cell function in cancer and autoimmunity","volume":"47","author":"Slansky","year":"2020","journal-title":"Semin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2014.917411","article-title":"Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection","volume":"33","author":"Cunningham","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12026-017-8978-z","article-title":"T Cell subsets: an integral component in pathogenesis of rheumatic heart disease","volume":"66","author":"Toor","year":"2018","journal-title":"Immunol Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1960.tb42854.x","article-title":"The concept of autoantibodies in rheumatic fever and in the postcommissurotomy state","volume":"86","author":"Kaplan","year":"1960","journal-title":"Ann N Y Acad Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/1.6.988","article-title":"Rheumatic fever, rheumatic heart disease, and the streptococcal connection: the role of streptococcal antigens cross-reactive with heart tissue","volume":"1","author":"Kaplan","year":"1979","journal-title":"Rev Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group a streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10875-009-9332-6","article-title":"Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease","volume":"30","author":"Guilherme","year":"2010","journal-title":"J Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.8.5448","article-title":"T Cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease","volume":"175","author":"Ellis","year":"2005","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-3083.2007.01974.x","article-title":"Rheumatic fever and rheumatic heart disease: genetics and pathogenesis","volume":"66","author":"Guilherme","year":"2007","journal-title":"Scand J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.2578225","article-title":"Myosin: a link between streptococci and heart","volume":"227","author":"Krisher","year":"1985","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.9.5662","article-title":"Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease","volume":"176","author":"Fae","year":"2006","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1086\/318076","article-title":"Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium","volume":"183","author":"Roberts","year":"2001","journal-title":"J Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(56)90186-3","article-title":"The relationship of sydenham's chorea to infection with group a streptococci","volume":"20","author":"Taranta","year":"1956","journal-title":"Am J Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nm892","article-title":"Mimicry and autoantibody-mediated neuronal cell signaling in sydenham chorea","volume":"9","author":"Kirvan","year":"2003","journal-title":"Nat Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e73516","DOI":"10.1371\/journal.pone.0073516","article-title":"Dopamine receptor autoantibodies correlate with symptoms in sydenham's chorea","volume":"8","author":"Ben-Pazi","year":"2013","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2022.102349","article-title":"Structural bases of T cell antigen receptor recognition in celiac disease","volume":"74","author":"Ciacchi","year":"2022","journal-title":"Curr Opin Struct Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nri2670","article-title":"Tissue-mediated control of immunopathology in coeliac disease","volume":"9","author":"Jabri","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.4.1585","article-title":"Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity","volume":"161","author":"van de Wal","year":"1998","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101619","article-title":"Structural basis of T cell receptor specificity and cross-reactivity of two HLA-DQ2.5-restricted gluten epitopes in celiac disease","volume":"298","author":"Ciacchi","year":"2022","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.005736","article-title":"Discriminative T-cell receptor recognition of highly homologous HLA-DQ2-bound gluten epitopes","volume":"294","author":"Dahal-Koirala","year":"2019","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade5800","article-title":"Identification of gluten T cell epitopes driving celiac disease","volume":"9","author":"Chlubnov\u00e1","year":"2023","journal-title":"Sci Adv"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1053\/j.gastro.2018.12.013","article-title":"Plasma cells are the most abundant gluten peptide MHC-expressing cells in inflamed intestinal tissues from patients with celiac disease","volume":"156","author":"Hoydahl","year":"2019","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1914308117","article-title":"A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease","volume":"117","author":"Ting","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev-immunol-040210-092915","article-title":"Integration of genetic and immunological insights into a model of celiac disease pathogenesis","volume":"29","author":"Abadie","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-018-0064-z","article-title":"Mechanisms by which gut microorganisms influence food sensitivities","volume":"16","author":"Caminero","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2019-0657","article-title":"Gut microbiome investigation in celiac disease: from methods to its pathogenetic role","volume":"58","author":"Sacchetti","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.06.041","article-title":"Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity","volume":"151","author":"Caminero","year":"2016","journal-title":"Gastroenterology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41594-019-0353-4","article-title":"T Cell receptor cross-reactivity between gliadin and bacterial peptides in celiac disease","volume":"27","author":"Petersen","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr Virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2007.07.007","article-title":"Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet","volume":"4","author":"Steinman","year":"2007","journal-title":"Neurotherapeutics"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2021.1978843","article-title":"Role of environmental factors in multiple sclerosis","volume":"21","author":"Zarghami","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.9.1651","article-title":"Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone","volume":"185","author":"Hemmer","year":"1997","journal-title":"J Exp Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ni835","article-title":"A functional and structural basis for TCR cross-reactivity in multiple sclerosis","volume":"3","author":"Lang","year":"2002","journal-title":"Nat Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.8.3746","article-title":"Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells","volume":"158","author":"Vergelli","year":"1997","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm7930","article-title":"Epstein-Barr Virus and multiple sclerosis","volume":"375","author":"Robinson","year":"2022","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220650","article-title":"Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis","volume":"219","author":"Schneider-Hohendorf","year":"2022","journal-title":"J Exp Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1038\/ncomms3623","article-title":"Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop","volume":"4","author":"Sethi","year":"2013","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.7.3764","article-title":"Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice","volume":"163","author":"Grogan","year":"1999","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/346183a0","article-title":"T-Cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis","volume":"346","author":"Ota","year":"1990","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.26.15317","article-title":"Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones","volume":"93","author":"Ausubel","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2000.0501","article-title":"Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease","volume":"16","author":"Martin","year":"2001","journal-title":"J Autoimmun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/70946","article-title":"Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease","volume":"5","author":"Hemmer","year":"1999","journal-title":"Nat Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324058","article-title":"Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal s-antigen","volume":"33","author":"Wildner","year":"2003","journal-title":"Eur J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"102942","DOI":"10.1016\/j.jaut.2022.102942","article-title":"Antigenic mimicry - the key to autoimmunity in immune privileged organs","author":"Wildner","year":"2022","journal-title":"J Autoimmun"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-2478(99)00071-1","article-title":"Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis","volume":"68","author":"Thurau","year":"1999","journal-title":"Immunol Lett"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05501-7","article-title":"Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides","volume":"612","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41577-022-00831-z","article-title":"Autoimmune TCRs cross-react with microbial and self-antigens","volume":"23","author":"Bordon","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/ng.3353","article-title":"Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk","volume":"47","author":"Hu","year":"2015","journal-title":"Nat Genet"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25350","article-title":"Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity","volume":"115","author":"Suri","year":"2005","journal-title":"J Clin Invest"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.313940","article-title":"Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire","volume":"287","author":"van Lummel","year":"2012","journal-title":"J Biol Chem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1502967112","article-title":"Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects","volume":"112","author":"Nakayama","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2337\/db17-0666","article-title":"Increased effector memory insulin-specific CD4(+) T cells correlate with insulin autoantibodies in patients with recent-onset type 1 diabetes","volume":"66","author":"Spanier","year":"2017","journal-title":"Diabetes"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.17.9279","article-title":"A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens","volume":"94","author":"Nicholson","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.153.7.3326","article-title":"A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire","volume":"153","author":"Kuchroo","year":"1994","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/379343a0","article-title":"Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein","volume":"379","author":"Brocke","year":"1996","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.5.2502","article-title":"Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99","volume":"159","author":"Ausubel","year":"1997","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/cimm.1998.1447","article-title":"Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein","volume":"193","author":"Ausubel","year":"1999","journal-title":"Cell Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand","volume":"6","author":"Bielekova","year":"2000","journal-title":"Nat Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200011)48:5<758::AID-ANA9>3.0.CO;2-2","article-title":"NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients","volume":"48","author":"Crowe","year":"2000","journal-title":"Ann Neurol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/80525","article-title":"Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. the altered peptide ligand in relapsing MS study group","volume":"6","author":"Kappos","year":"2000","journal-title":"Nat Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0449","article-title":"No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes","volume":"32","author":"Walter","year":"2009","journal-title":"Diabetes Care"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113954108","article-title":"Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse","volume":"108","author":"Crawford","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31368","article-title":"Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity","volume":"117","author":"Nakayama","year":"2007","journal-title":"J Clin Invest"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091578","article-title":"Glatiramer acetate immunomodulation: evidence of neuroprotection and cognitive preservation","volume":"11","author":"Kasindi","year":"2022","journal-title":"Cells"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510x(79)90058-3","article-title":"The effect of cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs","volume":"42","author":"Keith","year":"1979","journal-title":"J Neurol Sci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7300","article-title":"Human and murine CD4 T cell reactivity to a complex antigen: recognition of the synthetic random polypeptide glatiramer acetate","volume":"165","author":"Duda","year":"2000","journal-title":"J Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.13.7452","article-title":"Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells","volume":"97","author":"Neuhaus","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1177\/0897190017725984","article-title":"Development of Glatopa(R) (Glatiramer acetate): the first FDA-approved generic disease-modifying therapy for relapsing forms of multiple sclerosis","volume":"31","author":"Bell","year":"2018","journal-title":"J Pharm Pract"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01564","article-title":"Immunological aspects of approved MS therapeutics","volume":"10","author":"Rommer","year":"2019","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.08.014","article-title":"Negative selection, epitope mimicry and autoimmunity","volume":"49","author":"Rose","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002694","article-title":"Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs)","volume":"9","author":"Ragone","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.5.705","article-title":"High frequencies of naive melan-A\/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals","volume":"190","author":"Pittet","year":"1999","journal-title":"J Exp Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020242","article-title":"Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2\/Melan-a peptide multimer(+) CD8(+) T cells in humans","volume":"196","author":"Dutoit","year":"2002","journal-title":"J Exp Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.10.5696","article-title":"Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive melan-a-specific CTL","volume":"169","author":"Rubio-Godoy","year":"2002","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535805","article-title":"Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with melan-a peptide","volume":"36","author":"Appay","year":"2006","journal-title":"Eur J Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41467-019-08534-1","article-title":"Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy","volume":"10","author":"Rosato","year":"2019","journal-title":"Nat Commun"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03368-8","article-title":"Identification of bacteria-derived HLA-bound peptides in melanoma","volume":"592","author":"Kalaora","year":"2021","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal5240","article-title":"Analysis of fusobacterium persistence and antibiotic response in colorectal cancer","volume":"358","author":"Bullman","year":"2017","journal-title":"Science"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B123","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.immuni.2021.02.014","article-title":"Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery","volume":"54","author":"Chiou","year":"2021","journal-title":"Immunity"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1177\/17588359211011455","article-title":"Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection","volume":"13","author":"Ottaiano","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-20-0814","article-title":"Viral molecular mimicry influences the antitumor immune response in murine and human melanoma","volume":"9","author":"Chiaro","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03125-w","article-title":"Functional virus-specific memory T cells survey glioblastoma","volume":"71","author":"Ning","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e954501","DOI":"10.4161\/21624011.2014.954501","article-title":"Molecular mimicry of MAGE-A6 and mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8(+) T-cell responses","volume":"3","author":"Vujanovic","year":"2014","journal-title":"Oncoimmunology"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1042\/bcj20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem J"},{"key":"B129","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12967-022-03512-6","article-title":"Molecular mimicry between tumor associated antigens and microbiota-derived epitopes","volume":"20","author":"Ragone","year":"2022","journal-title":"J Transl Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax0701","article-title":"Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage","volume":"369","author":"Fluckiger","year":"2020","journal-title":"Science"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01406-6","article-title":"Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade","volume":"27","author":"Andrews","year":"2021","journal-title":"Nat Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2017.07.009","article-title":"Reactivity toward bifidobacterium longum and enterococcus hirae demonstrate robust CD8(+) T cell response and better prognosis in HBV-related hepatocellular carcinoma","volume":"358","author":"Rong","year":"2017","journal-title":"Exp Cell Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002754","article-title":"Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma","volume":"9","author":"Br\u00e4unlein","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002531","article-title":"Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations","volume":"9","author":"Li","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma","volume":"21","author":"Linnemann","year":"2015","journal-title":"Nat Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"B139","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12967-018-1662-9","article-title":"Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients","volume":"16","author":"Petrizzo","year":"2018","journal-title":"J Transl Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135597","article-title":"Commensal bacteria stimulate antitumor responses via T cell cross-reactivity","volume":"5","author":"Bessell","year":"2020","journal-title":"JCI Insight"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N Engl J Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01365-2","article-title":"Tumour neoantigen mimicry by microbial species in cancer immunotherapy","volume":"125","author":"Boesch","year":"2021","journal-title":"Br J Cancer"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1796","article-title":"Identification of cross-reactive peptides using combinatorial libraries circumvents tolerance against her-2\/neu-immunodominant epitope","volume":"176","author":"Lustgarten","year":"2006","journal-title":"J Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.5.833","article-title":"Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes","volume":"185","author":"Theobald","year":"1997","journal-title":"J Exp Med"},{"key":"B146","article-title":"Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of melan-A\/MART-1 optimized analogues","volume":"63","author":"Carrabba","year":"2003","journal-title":"Cancer Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.6.2539","article-title":"Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues","volume":"157","author":"Parkhurst","year":"1996","journal-title":"J Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.2.948","article-title":"Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL","volume":"165","author":"Chen","year":"2000","journal-title":"J Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.970914","article-title":"Heteroclitic XBP1 peptides evoke tumor-specific memory cytotoxic T lymphocytes against breast cancer, colon cancer, and pancreatic cancer cells","volume":"3","author":"Bae","year":"2014","journal-title":"Oncoimmunology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1252895","article-title":"An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules","volume":"6","author":"Dao","year":"2017","journal-title":"Oncoimmunology"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-12-1516","article-title":"Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides","volume":"18","author":"Filipazzi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800080105","article-title":"Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen","volume":"105","author":"Speiser","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Morgan","year":"2013","journal-title":"J Immunother"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585385","article-title":"Empirical and rational design of T cell receptor-based immunotherapies","volume":"11","author":"Jones","year":"2020","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006034","article-title":"Identification of a titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells","volume":"5","author":"Cameron","year":"2013","journal-title":"Sci Transl Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav3487","article-title":"Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy","volume":"366","author":"Gil-Cruz","year":"2019","journal-title":"Science"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"B159","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11936-019-0731-6","article-title":"Cardiotoxicity of immune checkpoint inhibitors","volume":"21","author":"Zhang","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2003.11.005","article-title":"A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes","volume":"40","author":"Nino-Vasquez","year":"2004","journal-title":"Mol Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.12","article-title":"Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors","volume":"94","author":"Szomolay","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf3700","article-title":"TCR-engineered T cell therapy in solid tumors: state of the art and perspectives","volume":"9","author":"Baulu","year":"2023","journal-title":"Sci Adv"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.iotech.2019.06.003","article-title":"T-Cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation","volume":"2","author":"Bentzen","year":"2019","journal-title":"Immunooncol Technol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4303","article-title":"T Cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexes","author":"Bentzen","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo6135","article-title":"Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy","volume":"14","author":"Kim","year":"2022","journal-title":"Sci Transl Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omto.2022.11.007","article-title":"A library of cancer testis specific T cell receptors for T cell receptor gene therapy","volume":"28","author":"de Rooij","year":"2023","journal-title":"Mol Ther Oncolytics"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.02.017","article-title":"Preclinical strategies to identify off-target toxicity of high-affinity TCRs","volume":"26","author":"Bijen","year":"2018","journal-title":"Mol Ther"},{"key":"B168","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1074\/mcp.R119.001743","article-title":"The human immunopeptidome project: a roadmap to predict and treat immune diseases","volume":"19","author":"Vizca\u00edno","year":"2020","journal-title":"Mol Cell Proteomics"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002071","article-title":"HLA ligand atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy","volume":"9","author":"Marcu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B170","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction","volume":"183","author":"Wells","year":"2020","journal-title":"Cell"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PloS Comput Biol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141264","article-title":"Solving an MHC allele-specific bias in the reported immunopeptidome","volume":"5","author":"Klatt","year":"2020","journal-title":"JCI Insight"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4605","article-title":"IEDB-3D 2.0: structural data analysis within the immune epitope database","volume":"32","author":"Mendes","year":"2023","journal-title":"Protein Sci"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.12.010","article-title":"Improving T cell receptor on-target specificity via structure-guided design","volume":"27","author":"Hellman","year":"2019","journal-title":"Mol Ther"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01210","article-title":"Interpreting T-cell cross-reactivity through structure: implications for TCR-based cancer immunotherapy","volume":"8","author":"Antunes","year":"2017","journal-title":"Front Immunol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-018-0130-4","article-title":"T Cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability","volume":"14","author":"Riley","year":"2018","journal-title":"Nat Chem Biol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.664514","article-title":"Contribution of T cell receptor alpha and beta CDR3, MHC typing, V and J genes to peptide binding prediction","volume":"12","author":"Springer","year":"2021","journal-title":"Front Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s42003-021-02610-3","article-title":"NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCR\u03b1 and \u03b2 sequence data","volume":"4","author":"Montemurro","year":"2021","journal-title":"Commun Biol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s42256-021-00383-2","article-title":"Deep learning-based prediction of the T cell receptor-antigen binding specificity","volume":"3","author":"Lu","year":"2021","journal-title":"Nat Mach Intell"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1002\/prot.25260","article-title":"ATLAS: a database linking binding affinities with structures for wild-type and mutant TCR-pMHC complexes","volume":"85","author":"Borrman","year":"2017","journal-title":"Proteins"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx971","article-title":"STCRDab: the structural T-cell receptor database","volume":"46","author":"Leem","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx286","article-title":"McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences","volume":"33","author":"Tickotsky","year":"2017","journal-title":"Bioinformatics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1212546\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T20:30:08Z","timestamp":1688675408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1212546\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":182,"alternative-id":["10.3389\/fimmu.2023.1212546"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1212546","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"article-number":"1212546"}}